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Projecting the future demands for vascular sur-
geons is difficult. Variations in new and existing
technologies, changes in financing of health care,
and the epidemiology of vascular disease affect the
need for trained vascular surgeons. By examining the
past growth rate and use of major vascular proce-
dures, some insight may be gained into the work-
force requirements for future vascular surgeons.
California was the focus of this study because it is the
most populous state and because, although it is far
from representative of all states, its recent history is
at the cutting edge of managed care. By studying the
interval between 1982 and 1994, one could expect
some substantial changes in procedures performed
as managed care became more competitive. The
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period of study begins just prior to the introduction
of Medicare diagnostic related groups (DRGs) in
1983 and extends to a time of increasing dominance
of managed care and a state of increasingly aggres-
sive use of selected contracting by major private and
public purchasers of medical healthcare.
Procedure mortality rates have been clearly linked
to hospital volume for major vascular surgery.1-5 In
the past, it has been argued that poor outcomes will
result if major operative procedures are directed away
from high-volume hospitals to low-volume hospitals
based on cost alone.1,6 The study of volume changes
in hospitals in a managed care environment may
demonstrate changes in contracting policies based on
costs and benefits of the insurers’ policies aimed at
either improved care or cost.
The California data presented here contribute to
this literature by providing trends in in-hospital
mortality rates for a large population over a rela-
tively long period of time. The data in this study
were analyzed for risk factors collected in the
California administrative data bases, namely age,
sex, whether admitted through an emergency room,
and selected diagnostic comorbidities. Like all hos-
pital claims data studies, this analysis is subject to
important limitations, namely the lack of detailed
clinical measures of disease severity and the limita-
tion of mortality data as it relates to death occurring
in the hospital. However, these data provide an
overview of progress made in improving the safety
of vascular surgery and provide further evidence of
the extent to which these procedures are performed
across hospitals. In addition, we hope to determine
whether peripheral angioplasty is a substitute for
LEAB and compare rates of growth for these pro-
cedures to that for coronary artery bypass (CABG)
and coronary angioplasty procedures. And finally
the paper will examine the relationship between
hospital volume and mortality.
METHODS
Data on procedures, inpatient mortality rates,
and patient demographics and comorbidities were
derived from the 1982-1994 California patient dis-
charge data compiled annually by the Office of
Statewide Health, Planning and Development
(OSHPD). The data contain all non-federal inpatient
hospital discharges that occurred within the state
between 1982 and 1994. Frequencies of vascular and
other reported procedures were calculated from first-
listed ICD-9 principal procedure codes. Codes used
to define procedure categories, provided in Appendix
A, were derived from prior research.7,8 Annual hos-
pital procedure volumes were calculated for each hos-
pital for each procedure. Inpatient mortality rates
were obtained from patient discharge status.
Annual per-capita volume of procedures was cal-
culated per 1000 population for each year and was
then age- and sex-adjusted using 12 age and sex cat-
egories. Rates reported are based on the 1990
California age and sex distribution. Annual California
population by age and sex was obtained from Bureau
of the Census estimates.
Changes in age-adjusted procedure rates over time
were plotted and compared with the growth in lower
extremity angioplasty procedures to examine whether
there appeared to be a substitution effect occurring. A
decline in the growth of LEAB procedures accompa-
nied by continued strong growth in the number of
lower extremity angioplasty procedures would suggest
that substitution is occurring. One difficulty encoun-
tered was that lower extremity angioplasty was coded
under “other vessel repairs” during this period. We use
the classification developed by Tunis et al.8 (see
Appendix) to categorize other vessel repairs into pro-
cedures likely (presence of peripheral vascular disease
diagnosis codes), possible (presence of diabetes com-
plication codes), and unlikely to be lower extremity
angioplasty procedures. We compare the experience of
the growth in LEAB and peripheral angioplasty proce-
dures with that of CABG and PTCA procedures to
further examine the issue of whether substitution
effects may be occurring.
Multiple logistic regression was used to esti-
mate the partial relationships between inpatient
hospital mortality and observable predictor vari-
ables for each surgical procedure. Each hospital
admission for a given surgical procedure during the
period 1982 to 1994 was included as an observa-
tion where predictor variables consisted of the fol-
lowing categorical variables: age category, gender,
year of surgery, whether admission was through the
emergency room, and number of hospital surgeries
for that procedure during the year. Comorbidities
reported as secondary diagnoses and likely to affect
mortality outcomes were identified only for LEAB,
where diabetes was identified as a potential addi-
tional risk factor. Presence of a secondary diagnosis
of diabetes was, therefore, included as an addition-
al predictor variable in the LEAB mortality regres-
sion. Discharges for ruptured and unruptured
aneurysms were estimated separately.
The number of surgeries was categorized into low
volume (under 20 surgeries for the surgical procedure
during the year), moderate volume (20 to 49 surg-
eries), and high volume (50 or more for AAA and 50
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to 99 and 100 or more for LEAB and CEA). The use
of an additional volume category, more than 100 pro-
cedures for LEAB and CEA, reflects the larger vol-
ume observed at hospitals for these procedures. More
than 100 procedures in a year at a hospital for AAA is
a very rare event. The null hypothesis of no trend in
inpatient mortality rates against the alternative
hypothesis of a downward trend was tested using the
Spearman rank correlation test.9 Analyses were com-
pleted using the SAS Statistical Software Package.10
RESULTS
Growth in procedures
A total of 100,963 LEAB; 106,493 CEA; 35,130
unruptured AAA; and 7327 ruptured AAA primary
procedures were reported for non-federal California
hospitals between 1982 and 1994. Whereas the
absolute number of LEAB and AAA procedures grew
26.4% and 35.2%, respectively, over the period, the
age-adjusted population rates grew just 7.1% and
7.7%, respectively. This difference between the age-
adjusted rates and absolute procedure numbers
reflects the growth and aging of the California pop-
ulation over the period. Because the age-adjusted
rates represent a better indication of growth for a
given population, we focus on these rates below.
Figure 1 graphs the growth in the rate of each of
the procedures per 100,000 population, age- and sex-
adjusted to reflect the 1990 California population. As
can be seen in Figure 1, LEAB procedure rates rose
very slightly until 1990 and then appeared to level off.
Abdominal aortic aneurysm repair rates increased a
total of 34.2% until 1988 and then began a trend back
downward through 1994.
Carotid endarterectomies showed a far more
interesting pattern, increasing about 27.2% between
1982 and 1984 and then sharply decreasing, from
just over 40.7 procedures per 1000 in 1984 to
22.0 procedures per 100,000 in 1989. Carotid
endarterectomy procedures have since rebounded
to 28.5 procedures per 100,000 population in
1994 with most of that increase occurring by 1992.
The dips and increases in CEA procedures no
doubt followed the literature on the effectiveness
and risks of the surgery. Overall, however, there has
been a decline in the age-adjusted population rates
since the early 1980s.
For LEAB, one might hypothesize that the lack
of a greater increase in procedure rates results, in
part, from the growth of lower extremity angioplas-
ty procedures; that is, a substitution effect may have
occurred. Figure 2 shows that peripheral angioplas-
ty procedures increased sharply from 1982 to 1989,
consistent with the creation of new hospital angio-
plasty capacity, and then leveled off. Using our defi-
nitions of likely and possible angioplasty procedures,
we estimate that the number of hospitals performing
peripheral angioplasty procedures grew from 3 in
1983-1984 to 27 in 1991 then decreased to 25 hos-
pitals in 1994. In a comparison of Figures 1 and 2,
there appears to be no substitution of peripheral
angioplasty for LEAB procedures. Adding together
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Fig. 1. Changes in major vascular procedures are shown with adjustments for age and sex to
reflect the 1990 California population.
the age-adjusted procedure rates for LEAB and
angioplasty shows no growth in the combined rates
since 1990.
These trends may be compared to CABG and
PTCA procedure rates for California between 1982
and 1994, shown in Figure 3. The age-adjusted rates
for CABG grew by 31.0% between 1982 and 1994,
from 62.3 to 81.6 procedures per 100,000 popula-
tion, with no growth over the last 3 years. But the
growth rates were sharply higher for PTCA, from
60.0 to 113.8 procedures per 100,000 population
between 1987 (the first year reliable figures were
available) and 1994. The growth in PTCA since
1987 has shown no signs of abating. Coronary
angioplasty was performed in 115 hospitals in
California in 1994. The procedure rates for PTCA
were approximately 10 times more common than
peripheral angioplasty in 1994.
Distribution of procedures across low-, moder-
ate-, and high-volume hospitals
Figure 4 shows the percentage of each of the
three procedures done in low-volume hospitals,
defined as hospitals with fewer than 20 discharges
for the procedure within the year for each year
between 1982 and 1994. The percentage of all
LEAB and AAA procedures done at low-volume
hospitals generally declined over the period, from
27.0% in 1982 to 16.5% in 1994 for LEAB and from
60.0% in 1982 to 49.1% in 1994 for AAA.
Conversely, the percentage of procedures done in
high-volume hospitals (more than 50 procedures)
increased from 33.7% in 1982 to 40.9% for LEAB
but remained relatively constant (9.4% in 1983 and
9.3% in 1994) for AAA. The hospital volume rates
for AAA procedures clearly reflect lower overall rates
for this procedure and, perhaps, the fact that approx-
imately 15% of these procedures were for patients
with ruptured aneurysms, probably treated at the
closest hospital.
The decrease in the percentage of procedures
done in low-volume hospitals does not appear to be
a result of an increasing concentration of the hospi-
tals performing the procedure. The number of hos-
pitals performing LEAB and AAA has increased
between 1982 and 1994, with the number of hospi-
tals performing greater than 20 procedures more
than doubling (29 to 58) for AAA and increasing
from 113 to 152 for LEAB during the period. The
average number of procedures being done at hospi-
tals with at least 20 procedures has remained rela-
tively constant for both AAA and LEAB. Thus, the
decreased percentage of LEAB and AAA procedures
being done in low-volume hospitals is a result of
more hospitals performing more procedures per year
rather than of the procedures being concentrated in
fewer hospitals. The percentage of CEA procedures
done in low-volume hospitals appears to be inverse-
ly related to the rise and fall of the procedure rates,
as shown in Figure 1. As the number of age-adjust-
ed CEA procedures per 100,000 declined, the per-
centage of procedures performed in low-volume
hospitals increased. Both trends were reversed in the
1990s with the percentage of CEA procedures per-
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Fig. 2. Trends in peripheral angioplasty procedures are shown with adjustments for age and
sex to reflect the 1990 California population.
formed at low-volume hospitals in 1994 (15.6%)
only slightly below the percentage performed at
low-volume hospitals in 1982 (17.2%).
In-hospital mortality rates
Given the above trends in procedure growth and
the extent to which procedures occurred in low-,
moderate-, and high-volume hospitals, we now
describe in-hospital mortality rates for each of the
three procedures.
In these analyses we divide AAA into ruptured
and unruptured aneurysms using the principal diag-
nostic code. As seen in Figure 5, annual in-hospital
death rates declined over this period for LEAB,
CEA, and unruptured AAA. There was no upward
or downward trend for ruptured AAA. Comparing
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Fig. 4. Percentage of procedures performed at low-volume hospitals.
Fig. 3. Changes in number of CABG/PTCA procedures is shown with adjustments for age
and sex to reflect the 1990 California population.
the two 5-year periods, 1982-1986 and 1990-1994,
death rates decreased from 4.2% to 3.3% for LEAB,
from 9.2% to 6.2% for unruptured AAA, and from
1.6% to 1.0% for CEA (p < 0.0001). Figure 6 shows
in-hospital death rates for each of the procedures for
low-, moderate-, and high-volume hospitals for the
period 1990-1994 for LEAB and CEA. Figure 7
shows these rates for ruptured and unruptured AAA.
There is a clear pattern of higher-volume hospitals
consistently having lower mortality rates. However,
these results present bivariate relationships, not con-
trolling for patient risk factors.
Logistic regression models were estimated to
identify the partial effects of time trend and hospital
procedure volume on in-hospital mortality rates
between 1982 and 1994 after accounting for differ-
ential observable risks. Tables 1 and 2 provide the
descriptive statistics and logistic regressions, respec-
tively, for each procedure.
Risk factors are controlled through a set of cate-
gorical variables denoting age category, sex, whether
admitted through the emergency room, and, for
LEAB, whether there is a secondary diagnosis of dia-
betes. The effect of a time trend on mortality rates is
measured by a set of variables denoting the year the
surgery occurred and the effect of hospital proce-
dure. Volume for LEAB and CEA is measured by
whether the hospital performed fewer than 20 pro-
cedures, 20 to 49 procedures, 50 to 99 procedures,
or 100 or more procedures during the year the
surgery occurred. For AAA we collapse the last two
categories because hospitals almost never have more
than 100 AAA procedures during a single year.
Table 2 reports mortality odds ratios relative to
the omitted risk category for each variable. These
omitted categories are patients under age 45, female
patients, patients not admitted through an emer-
gency room, patients admitted for the procedure in
1982, patients without a diabetes secondary diagno-
sis, and patients admitted to a hospital performing
fewer than 20 of the surgical procedures in the year
admitted. For example, an odds ratio of 4.1 for the
admitted-through-the-emergency-room variable
(Table 2 for LEAB) means that, after controlling for
the effects of the other variables, patients admitted
through the emergency room have 4.1 times the
odds of dying during the hospital stay as patients not
admitted through the emergency room.
We consider the results for ruptured AAAs first
because of the emergency nature of the surgery and
the very high inpatient mortality rates observed. Of
the 7327 procedures performed during the 14 years,
47.9% of admissions resulted in inpatient death.
There was no downward (or upward) trend in mor-
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Fig. 5. Trends in mortality rate data are shown.
tality rates over the period of observation, but there
was a strong relationship between the number of
procedures done by a hospital and the in-hospital
mortality rate. The odds of dying in a hospital that
performed 20 to 49 AAA procedures was just 73.5%
of the rate for dying in a hospital that performed
fewer than 20 procedures. In high-volume hospitals
the odds of dying were just 49.1% of the odds for
low-volume hospitals. Increasing age was signifi-
cantly associated with higher odds of dying as were
admission through the emergency room (67.0% of
cases) and being female (16.9% of cases).
The mortality rates for the other procedures dur-
ing this period were 7.56% of the 35,130 patients
with unruptured AAA, 3.81% of the 100,963
patients undergoing LEAB, and 1.3% of the 106,493
patients undergoing CEA. For each of these three
procedures, there was a clear negative time trend in
in-hospital mortality rates over the period (p < 0.01).
The odds ratio of dying to surviving a hospital stay
decreased in 1994 to 41.5% of 1982 odds for unrup-
tured AAA, to 39.9% of 1982 odds for CEA, and to
59.8% of the 1982 odds for LEAB.
Comparing the odds of dying for the high- and
moderate-volume hospitals with low-volume hospi-
tals, we find that the odds of dying were significant-
ly higher in the low-volume hospitals for all of these
procedures. The relationship of volume to odds of
dying was not as large for unruptured AAA as for
ruptured aneurysm. Hospitals performing 20 to 49
procedures and greater than 50 procedures had odds
of death of 77.6% and 83.8%, respectively, of the
odds for low-volume hospitals. For both CEA and
LEAB the odds ratios were always lower for hospi-
tals categorized as having a higher volume of proce-
dures. In both cases, the hospitals with the highest
volume, more than 100 procedures per year, had
odds ratios approximately two thirds of those for the
lowest-volume hospitals. These results are similar to
the unadjusted rates. Between 1982 and 1994, 4.6%
of low-volume admissions for LEAB and 3.2% of
high-volume admissions for LEAB died while in the
hospital; for CEA the in-hospital mortality rates
were 1.7% and 1.2% for low- and high-volume hos-
pitals, respectively. These results suggest that the
regression adjustments had little effect on the hospi-
tal volume odds ratios, only slightly increasing the
effect of hospital volume on mortality rates.
With respect to other risk factors explaining the
three procedures, as expected, increasing age is a
strong predictor of mortality rates. Relative to
female patients, male patients are significantly less
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Fig. 6. Mortality rates of LEAB and CEA surgeries are shown by number of surgeries at each
hospital per year.
likely to die from (and much more likely to receive)
an AAA procedure (ruptured or unruptured) but
not from the other procedures. Admissions for a
procedure through the emergency room are associ-
ated with much higher mortality rates: the odds of
dying are 2.4 times as great for CEA, 4.1 times as
great for LEAB, and 4.6 times as great for unrup-
tured AAA when the admission is through the emer-
gency room than when the admission is elective for
the procedure.
DISCUSSION
From this study, several observations may be
made regarding trends in the use of three vascular
procedures and their associated mortality rates in
California. (1) There appears to be a picture of min-
imal growth in procedure frequency with negligible
changes when the age distribution of the state is
controlled. (2) There has been a steady decline in
hospital mortality rates for the three signature vas-
cular procedures in all age groups. (3) Over the 14-
year span, hospital volume has increased, changing
the percentage of low-volume hospitals. Thus over-
all, the percentage of procedures performed in low-
volume hospitals has changed only as a result of the
increasing volume in previously low-volume hospi-
tals. (4) And finally, lower extremity angioplasty
increased; it does not have a significant impact on
LEAB. Each of these observations has occurred in
an era of changing socioeconomics and training in
vascular surgery.
While the absolute number of annual vascular
surgery procedures has increased (26% to 35%) in
California over the time of study, the age-adjusted
population rates have changed only 7%. These find-
ings are consistent with Stanley’s report for all vas-
cular procedures in the United States.8 Without
changes in the incidence of the disease in the gener-
al population, this observation is not unexpected.
Taken as a whole, these results suggest that there is
little reason to believe that there will be any signifi-
cant increases in vascular procedure rates in
California in the foreseeable future.
Between 1982 and 1994 there has been a signif-
icant decline in mortality for the three procedures.
The improvement in surgical mortality is multi-
faceted. First, beginning in 1982 a special certificate
examination was given by the American Board of
Surgery (ABS) to identify surgeons with added qual-
ifications in general vascular surgery. The intent of
this program was to identify surgeons with special
qualifications and expertise in vascular surgery. In
1996 Stanley reported that in 1985, 41% of all vas-
cular procedures performed in the United States
were by members of either national or regional vas-
cular societies.8 This number increased dramatically
by 1992 when 51% of all vascular procedures were
performed by members of these societies.
Unfortunately, in this study we do not have physi-
cian-specific data to determine the prior training.
Previous studies determining outcomes based on
discharge summaries have concluded that, whereas
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Fig. 7. Mortality rates of abdominal aortic aneurysm repairs are shown by number of surg-
eries performed at each hospital per year.
hospital volume is an important determinant of out-
come, physician-specific volume only correlates with
ruptured aneurysms and the performance of carotid
endarterectomy.2 In addition, there is little physi-
cian-specific data on the performance of LEAB other
than that reported by Hertzer.11 Here, a metropoli-
tan registry revealed that better outcomes (fewer
deaths and amputations) occurred when physicians
had greater experience and training. In 1984, Flood
and colleagues, using detailed adjustment for patient
severity, also concluded that better outcomes
occurred when surgeons had greater experience with
“intraabdominal artery procedures.”12,13 A positive
correlation was also found with board certification
and nonvascular procedures. These reports predated
the certification procedure begun in 1982. In a later
study, Pilcher reported surgeon-specific data, again
suggesting that training and expertise is an impor-
tant determinant of surgical outcome in AAA.14
An alternative explanation for the drop in inpa-
tient mortality rates during this interval is that it is
the result of the decrease in hospital length of stay.
It is possible that patients who die following dis-
charge from the hospital are undetected by this
study or that patients were transferred to another
facility and thus also were undetected by this study.
This question was addressed by Hannan et al. in a
study of AAA reports in New York.1 The authors did
not find that the results were affected by transfers
nor by shortened length of stay.
Consistent with previous research for numerous
surgical procedures, low-volume hospitals are gen-
erally found to have significantly higher mortality
rates than higher-volume hospitals.15-19 Hannan et
al. reported on a series of 3570 elective AAA resec-
tions and found an inverse relationship between
case volume for surgeons and mortality rate.1 From
studying the Veterans Administration system,
Kazmers and colleagues reported the 4-year results
of veteran patients undergoing elective repair of
abdominal aortic aneurysms.20 The mortality rate
after repair of nonruptured aneurysms in high-vol-
ume hospitals was 4.2% as compared with 6.7% in
low-volume hospitals. The authors noted, though,
that some low-volume hospitals did have excellent
outcomes. However, there was a direct relationship
between the illness severity and hospital mortality.
Rutherford has emphasized the importance of a
severity-of-illness index for vascular surgery for ade-
quate risk-adjusting outcomes.21 Unfortunately,
abstracting large patient populations would be 
an enormous task and would be best performed
prospectively. In this study, patients were catego-
rized for emergency admissions, for age, for gender,
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Table I. Means for LEAB, CEA, and AAA Patients, California, 1982-1994
Variable Description LEAB CEA Unrup AAA Rup AAA
Patient died in hospital 0.0381 0.0130 0.0756 0.4788
(0.1914) (0.1131) (0.2643) (0.4996)
Patient’s age between 45 and 54 0.0879 0.0459 0.0266 0.0162
(0.2831) (0.2019) (0.1610) (0.1264)
Patient’s age between 55 and 64 0.2359 0.2019 0.1684 0.1524
(0.4246) (0.4014) (0.3742) (0.3595)
Patient’s age between 65 and 74 0.3820 0.4358 0.4437 0.4103
(0.4859) (0.4959) (0.4968) (0.4919)
Patient’s age between 75 and 84 0.2198 0.2788 0.2646 0.3326
(0.4141) (0.4484) (0.4412) (0.4712)
Patient’s age 85 or over 0.0469 0.0331 0.0322 0.0869
(0.2113) (0.1790) (0.1766) (0.2818)
Male patient 0.5835 0.5567 0.7901 0.8313
(0.4930) (0.4968) (0.4072) (0.3745)
Admitted through emergency room 0.0734 0.0602 0.1045 0.6674
(0.2608) (0.2379) (0.3059) (0.4712)
Patient has diabetes 0.2459
(0.4306)
Hospital did 20 to 49 procedures/yr 0.4114 0.3225 0.4123 0.3105
(0.4921) (0.4674) (0.4923) (0.4627)
Hospital did 50 to 99 procedures/yr 0.2805 0.3305 0.0951 0.0465
(0.4493) (0.4704) (0.2934) (0.2107)
Hospital did 100+ procedures/yr 0.0950 0.1734
(0.2932) (0.3786)
N 100,963 106,493 35,130 7327
For AAA regressions, number of both unruptured and ruptured AAA procedures are included to determine number of hospital proce-
dures per year.
and for whether they had diabetes mellitus. Using
comorbidities coded in discharge statistics is often
unreliable, and comorbidities coded this way were
in fact associated with a lower risk of in-hospital
death.22
As reported in previous statewide data, male
patients tend to be operated on more frequently
than female patients and are more likely to have poor
outcomes. The experience described here in rela-
tionship to carotid endarterectomies is also similar to
previously reported literature.19 In a report by Segal,
based on statewide data mortality, surgeon volume
and outcome were inversely related.23
Mortality studies involving surgical procedures
reveal a complex interaction among hospital charac-
teristics, physician expertise, and severity of patient
illness. Improved patient outcomes with increased
hospital or physician volume suggests several possi-
bilities. Investigators have argued that this phenom-
enon reflects either an existing referral system to
capable surgeons or that “practice makes perfect.”
Luft and colleagues in 1975 found that, in certain
procedures (open heart and vascular), outcome was
directly related to the volume of procedures per-
formed by the surgeon. The more procedures the
surgeon performed, the better the results.6 Certain
other procedures, such as total hip replacements,
required a shorter learning curve whereas others,
such as hernia repair, were not volume dependent. It
would follow that when efforts are made to increase
volumes at low-volume hospitals because of cost,
mortality should rise. In this study we found
changes in the distribution of case loads in previous-
ly low-volume hospitals, particularly for CEA and
LEAB. The redistribution of these cases was not
associated with additional mortality. This finding is
similar to that found by Hannan who reported that
hospital volume was more important for nonrup-
tured aneurysms than for ruptured aneurysms.1
Hospital volume did, however, play an important
role for ruptured aneurysms. In New York there
were substantial increases in the number of AAA
repairs performed over the period of observation.
Surgeons who had low mortality rates experienced a
greater volume increase than did surgeons with high
mortality rates, suggesting a selective referral bias.
There are some important limitations to the
mortality analyses presented here. First, inpatient
mortality rates may have decreased to some extent
simply because lengths of stay have been decreasing
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Table II. Results of logistic regression of the likelihood of dying in hospital for LEAB, CEA, and AAA surgeries
Variable Description LEAB CEA Unrup AAA Rup AAA
Intercept p < 0.001 p < 0.001 p < 0.001 p < 0.001
Patient’s age between 45 and 54 1.36 0.39 0.99 0.78
p = 0.085 p = 0.003 p = 0.959 p = 0.727
Patient’s age between 55 and 64 2.36 0.40 1.14 1.17
p < 0.001 p = 0.001 p = 0.257 p = 0.816
Patient’s age between 65 and 74 3.75 0.50 1.75 1.99
p < 0.001 p = 0.015 p < 0.001 p = 0.318
Patient’s age between 75 and 84 5.82 0.79 2.79 3.02
p < 0.001 p = 0.420 p < 0.001 p = 0.109
Patient’s age 85 or over 7.71 0.86 4.55 4.48
p < 0.001 p = 0.619 p < 0.001 p = 0.031
Male patient 0.97 1.10 0.68 0.74
p = 0.327 p = 0.088 p < 0.001 p < 0.001
Admitted through emergency 4.10 2.47 4.55 1.68
room p < 0.001 p < 0.001 p < 0.001 p < 0.001
Patient has diabetes 0.89
p < 0.005
Hospital did 20 to 49 0.87 0.80 0.78 0.74
procedures/yr p < 0.001 p = 0.002 p < 0.001 p < 0.001
Hospital did 50 to 99 0.74 0.68 0.84 0.49
procedures/yr p < 0.001 p < 0.001 p = 0.017 p < 0.001
Hospital did 100+ procedures/yr 0.67 0.66
p < 0.001 p < 0.001
N 100,963 106,493 35,130 7327
Odds ratios are relative to omitted categories: age < 45, female, not admitted through ER, no diabetes (only for LEAB), hospital did
fewer than 20 procedures per year.
Year categorical variables are omitted from table.
For AAA regressions, number of both unruptured and ruptured AAA procedures are included to determine number of hospital proce-
dures per year.
over this time period, but this is unlikely based on
other similar studies. Second, the administrative data
used do not allow control for clinical variables that
might be confounding the results. An example of
this would be control for individuals who have fewer
critical vascular disease complications on average and
spend more time determining where they should go
for procedures, the result of which is healthier indi-
viduals selecting higher-volume hospitals. Then, the
relationship between lower mortality rates and high-
volume hospitals would, in part, be spurious because
of the unobserved relationship. However, the fact
that controlling for risk factors, including age and
admissions through the emergency room, did not
decrease the raw, unadjusted differences in mortality
observed across low- and high-volume hospitals sug-
gests the results are unlikely to be largely the result
of confounding variables.
We also examined whether a decrease would
occur in LEAB as a result of a switch to use of lower
extremity angioplasty as a primary procedure.
Although population rates for this procedure grew
substantially in the 1980s, the growth leveled off in
the 1990s, so it was clearly not responsible for the
recent lack of growth in LEAB procedure popula-
tion rates. There is certainly no reason to expect
growth if the procedure is being done at an appro-
priate rate in the population. And it is also possible
that declining disease prevalence is responsible for
these results. However, this appears unlikely given
the observed growth in CABG and PTCA rates over
this period, particularly the continued rise in the use
of PTCA in the 1990s.
In order to understand fully the value of these
procedures and the risks involved, one must of
course move beyond short-term mortality statistics
to examine patterns of late survival and arterial
patency. Thus, CEA adverse outcomes are generally
presented in terms of mortality and stroke preven-
tion. Similarly, LEAB procedures are justified in
terms of improved walking ability and decreased
amputation rates. In contrast to clinical trials data,
the California data presented here allow one to
assess general population trends. These data do sug-
gest that for these procedures (other than ruptured
aneurysms), associated in-hospital mortality risk has
been significantly decreasing over time and that the
data support the view that hospital volume is an
important determinant of outcome.
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Dr. Andris Kazmers (Detroit, Mich.). Dr. Manheim
and colleagues examined trends in mortality rates and use
of lower extremity bypass graft, carotid endarterectomy,
and abdominal aortic aneurysm repair in nonfederal
California hospitals between 1982 and 1994. With
California discharge data, the first listed ICD-9 procedure
code was used to identify subjects.
Lower extremity bypass graft procedures grew 26%,
and aortic aneurysm repairs grew 35%. There were no
increases in age-adjusted rates of abdominal aortic
aneurysm repair and leg bypass graft. An overall decline in
age-adjusted rates for carotid endarterectomy was noted.
An estimation of peripheral transluminal angioplasty
rates was made with methods used previously by Tunis et
al., who studied bypass grafts, angioplasty, and amputation
in Maryland. During both studies, there were no specific
ICD-9 codes available for percutaneous transluminal
peripheral artery angioplasty. Therefore, Tunis employed
indirect methods to estimate angioplasty rates but missed
22% of angioplasties and incorrectly identified 8% of
patients as having angioplasty who did not when the tech-
niques were validated at one medical center. Such tech-
niques as were used in the present study were challenged
by members of the vascular surgery community. Given the
study methods, patients who underwent angiplasty in
addition to lower extremity reconstruction would not
have been identified. Did you validate, and can you justify
the methods you used to identify the number of peripher-
al angioplasties performed?
Mortality rates decreased for extremity bypass grafts,
carotid endarterectomy, and repair of intact aneurysms,
and mortality rates for repair of ruptured abdominal aor-
tic aneurysms did not decrease. There were many changes
in the structure and process of care during the study peri-
od. The study period included the introduction of vascu-
lar surgery certification and major growth in vascular
surgery fellowship training. There were many changes in
the approach to vascular disease during this period. As an
example, mainly one operation, aortobifemoral bypass
graft, was performed to treat inflow disease at the start of
this study. Now, there are many suitable and accepted
alternatives to manage inflow disease. Do you think your
DISCUSSION
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APPENDIX
ICD-9 Procedure Codes Corresponding to
Diagnostic Categories
1. Vascular surgery procedures performed by vascu-
lar surgeons (and other surgeons): 38.00, 38.03,
38.04, 38.06, 38.08, 38.10, 38.12, 38.13, 38.14,
38.16, 38.18, 38.30, 38.33, 38.34, 38.36, 38.38,
38.40, 38.43, 38.44, 38.46, 38.48, 38.59, 38.60,
38.63, 38.64, 38.66, 38.68, 38.7, 38.80, 38.83,
38.84, 38.86, 38.88, 39.22, 39.24, 39.24, 39.26,
39.25, 39.27, 39.29, 39.30, 39.31, 39.40-39.43,
39.49, 39.50, 39.53-39.59, 39.80, 39.91, 39.93,
39.94, 39.98, 39.99.
2. Lower Extremity Arterial Bypass (LEAB): 39.25,
39.29.
3. Carotid Endarterectomy (CEA): 38.12.
4. Abdominal Aortic Aneurysm Repair (AAA):
38.34, 38.44, 38.64.
5. Peripheral Angioplasty: In 1995 a code was intro-
duced (39.50) for peripheral angioplasty; for
1982-1994, peripheral angioplasty was included
in 39.59 (other vessel repair). The codes below are
used to identify peripheral angioplasty procedures
for these earlier years and were developed by
Tunis et al., who reported this algorithm underes-
timated angioplasty procedures by about 15%. 
Defined as “Likely” if 39.59 is primary code and
39.61 not present and any of the following diagno-
sis codes is listed as either principal or secondary
diagnosis code: 250.7, 492.2, 440.2, 440.8, 440.9,
443., 444., 447.1.
Defined as “Possibly” if 39.59 is primary code,
39.61 is not present, none of the likely diagnostic
codes is present, and at least one of the following
codes is present: 250.(other than 250.7), 440.0,
440.1, 730.26, 730.27, 785.4, 681.11, 682.6,
682.7, 707.1, 996.1, 997.2.
Defined as “Other” if not included in “likely” or
“possibly.”
6. Coronary Artery Bypass Surgery (CABG):
36.10-36.16, 36.20, 36.30.
7. Coronary Angioplasty (PTCA): 36.01, 36.02,
36.05.
study methods were insensitive to these and other changes
in vascular surgical care that may have been responsible for
the improved outcomes?
Amputation data was not included in the first draft of
the manuscript. The manner in which amputations were
defined slso was not described in the manuscript.
The authors used procedure codes that included upper
and lower extremity vascular reconstructions. They
described the frequency of extremity bypass grafts, not just
lower extremity bypass grafts.
The authors identified low-volume hospitals as those
performing less than 20 procedures per year for each of
the vascular procedures examined. How and why was that
cutpoint chosen to define low-volume hospitals?
Mortality rate is a suitable outcome measure after
abdominal aortic aneurysm repair, but use of risk-adjusted
mortality rates would have been more revealing. Were other
outcomes assessed, such as limb loss after extremity bypass
graft or stroke after carotid endarterectomy? The California
database would have lended itself to assessment of such post-
operative complications and to assessment of illness severity.
Meaningful comparison of mortality rates between dif-
ferent hospital types and over time is not possible unless an
adjustment is made for differing illness severity. Hospital
mortality rates are related to surgical volume and to illness
severity. A study of aneurysm repairs performed in the
entire Veterans Affairs healthcare system showed hospital
level mortality rates were inversely related to surgical vol-
ume and directly related to mean illness severity of those
treated in each hospital. Are you able to exclude the pos-
sibility that the mortality rates were higher in low-volume
hospitals because the patients were older or sicker?
The California database used in this study would have
permitted illness severity to be better defined, risk adjust-
ment to be performed, and total vascular surgical volume to
be determined. Use of the only the first coded diagnosis to
identify subjects, as was done in this study, underestimates
the total number of vascular procedures, including periph-
eral angioplasty. How certain are you that use of these pro-
cedures was not much greater than you have estimated?
This study, by itself, does not support regionalization
of vascular surgical care. Shifting patients away from low-
volume hospitals could cause problems with access to care.
Further, many formerly low-volume hospitals climbed out
of this designation by increasing their vascular surgery vol-
ume. It would be interesting to focus on these hospitals
and see how often this change in activity was caused by the
availabilty of a freshly trained vascular surgeon.
I thank the Western Vascular Society for inviting me to
open the discussion of this interesting study.
Dr. William H. Pearce. In his presidential address, Dr.
Rutherford described a severity illness index that is difficult
to do in a prospective fashion. If you use the ICD-9 codes,
which were expanded from 5 to 25, you will find that hos-
pitals vary dramatically in their coding; there are some heavy
coders, and there are some hospitals that code very little.
A recent study that used the ICD-9 codes to look at
severity of illness found that hypertension and diabetes
were protective (Lezzoni et al. JAMA 1992;267:2197-
203). The patients with risk factors did better than other
patients, which is counter intuitive.
They found that patients who died tended to have
more coding for their discharge summary that confound-
ed the issues. Here, we use diabetes as one of the variables,
and it was protective as well. Therefore, the use of addi-
tional comorbidities on the basis of ICD-9 codes to risk
adjustment is not always accurate.
The choice of 20 or less procedures was arbitrary.
Unfortunately, one of the problems with hospital-based
data is that surgeons work at multiple hospitals. For exam-
ple, in your own study from the Veterans Affairs system,
some low-volume hospitals had excellent outcomes.
So, from one side of Erie Street to the other, there is
high volume at one hospital but low volume at the other.
We do not have data on surgeon volume as related to out-
come. Hospitals that climbed out of the low-volume cate-
gory may have hired a trained vascular surgeon and put
forth efforts in developing a vascular program. That has
been shown in the New York data as well.
How do hospitals become high volume? Does practice
makes perfect? Or is it selective referral pattern? This
means that physicians refer to surgeons that have low mor-
tality rates and, therefore, their volumes increase.
This notion has been tested in several studies, and it
appears that for aneurysm surgery this is true. Referrals of
patients of high-volume hospitals are to surgeons with low
mortality rates.
What is unmeasured in this study that leads low-vol-
ume hospitals to have higher mortality rates is unknown.
A prospective study with risk adjustment is needed.
Clearly, one must have a certain supporting hospital struc-
ture to perform high-quality vascular surgery. An intensive
care unit with a critical care support is needed to get some
of these patients through surgery.
A teaching hospital with residency tends to have bet-
ter results. In older studies, if the surgeons were board cer-
tified by the American Board of Surgery before vascular
boards, they tended to have better outcomes as well. It is
difficult to dissect this in the present study. For angioplas-
ties, we relied simply on Tunis et al.’s criteria for coding
for peripheral angioplasties.
The first listed ICD-9 code also underestimates the
prevalence. We wanted as pure a number as possible.
Certainly, we missed a number of vascular procedures, but
during this interval, there were close to 200,000 leg
bypass grafts, 100,000 carotid endarterectomies, and
about 35,000 aneurysm repairs performed.
Your final question regarded ruptured aneurysms. The
mortality rate for the 12-year period was 47%. There were
7,000 ruptured aneurysms. High-volume hospitals had
lower morality rates, which implies that low-volume hos-
pitals must have had mortality rates greater than 47%,
probably in the range of 60% or 70%.
As to the amputation question, the issue was added as an
afterthought particularly as you consider the paper by Tunis
et al. Amputation rates have declined on a national basis.
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Dr. Kaj Johansen (Seattle, Wash.). This was a wonder-
ful study. As Dr. Kazmers has indicated, it really raises as
many questions as it answers.
We have performed a similar study with Medicare dis-
charge data that looks only at unruptured aneurysm in the
state of Washington. Our study had much less relevance
than the one you correctly chose to examine in a large
populous state at the leading edge or, if you will, at the
precipice of managed care.
A finding from our study in Washington, however, was
noteworthy in view of what you showed here. One bar
graph appeared to show a decline in abdominal aortic
aneurysm mortality rates at low-volume hospitals to high-
volume hospitals from only 7% to 6%. What we showed,
with the same arbitrary cut points that you used, was almost
a trebling of mortality rates from high-volume hospitals to
low-volume hospitals for unruptured aneurysm operations.
Our results seemed to be much more compelling than
yours in confirming the proposal of Luft, Bunker, and
Einthoven that mortality rates have an inverse relationship
with hospital volumes. Could you comment on your find-
ing of only a single percentage point decline in hospital
mortality rates?
Dr. Pearce. There are really two questions and two
issues I would like to address there. The data, as flawed as
it is, is used to make health care decisions. Regionalization
is happening.
For example, in Chicago, they have designated one of
the hospitals as a center of excellence for cardiovascular
care. Policy makers know which hospitals have high and
low mortality rates.
I cannot explain why the low-volume hospitals had
only a 7% mortality rate. Now, this is from 1990 to 1994
as opposed to the 5% in the higher-volume hospitals. My
guess is that the higher-volume hospitals are seeing
juxtarenal aneurysms or other aneurysms that are more
complicated than in the low-volume hospital, but there is
no way to say for certain.
I had a long discussion with Dr. Jack DeLaria about
capitated health care in the Medicare population. It made
me think about the same issue that you discussed, which is
that in a capitated system you have a choice of operating
on some patients who may be costly to the system versus
those who are not. You will see that population-based vol-
umes in the next few years will start to decline. The num-
ber of aortic operations performed per population of
100,000 will go from 10 to 7. What you are not seeing is
the number of patients who die outside of the hospital
with ruptured aneurysms that are not autopsied. The sta-
tistics may not show the flip side of choosing not to oper-
ate; I think there will be incremental ratcheting down in a
capitated system. Each year there will be a decreasing
number of procedures performed per population and thus
reduced reimbursement. It is a slippery slope.
Dr. Julie Freischlag (Los Angeles, Calif.). I would like
to talk about choice. Certainly, in Veterans Affairs, we
have looked at risk-adjusted data for vascular surgery, and
Veteran Affairs actually does vascular surgery very well.
They looked at the outliers, which are usually about four
or five hospitals per year, that have a higher index of death
than unexpected. They actually investigate these hospitals
to see find the problem and pull those cases. It turns out
to probably be choice in the sense that the residents are
able to perform operations with perhaps not enough
supervision and with not enough saying that the patient
should not have that operation.
When I looked at your data, it almost seems that we
are getting better at that. Perhaps there are patients on
whom we are choosing not to operate, which is as they are
not going to survive and live 5 years.
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